scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
![GlobeNewswire](../../../Content/images/providers/GN.png)
scPharmaceuticals Inc. (SCPH)
Last scpharmaceuticals inc. earnings: 3/24 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
scpharmaceuticals.com
Company Research
Source: GlobeNewswire
Generated 1Q 2024 net FUROSCIX® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack Ended 1Q 2024 with cash and cash equivalents of $58.4 million Company to host investor conference call and webcast today, Tuesday, May 14, at 4:30pm ET BURLINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the first quarter ended March 31, 2024, and provided a business update. Business Update For the first quarter ended March 31, 2024, scPharmaceuticals reports: Net FUROSCIX revenue of $6.1 million, despite an estimated 10% negative impact to doses filled during the first quarter resulting from the Change Healthcare cyberattack as well as seasonality result
Show less
Read more
Impact Snapshot
Event Time:
SCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCPH alerts
High impacting scPharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
SCPH
News
- scPharmaceuticals to Present at the Jefferies Global Healthcare ConferenceGlobeNewswire
- scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceGlobeNewswire
- scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024GlobeNewswire
- scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) InjectionGlobeNewswire
SCPH
Earnings
- 5/14/24 - Beat
SCPH
Analyst Actions
- 5/15/24 - HC Wainwright
SCPH
Sec Filings
- 6/14/24 - Form 8-K
- 6/13/24 - Form 4
- 6/13/24 - Form 4
- SCPH's page on the SEC website